Table 1.
Variable | 2014 (n = 5,699; weighted N = 61,491,766) | 2016 (n = 4,886; weighted N = 61,799,158) |
---|---|---|
Among all women | ||
Not using contraception | 38.6 | 36.5 |
Using contraception | 61.4 | 63.5 |
Among sexually active women not seeking pregnancya | ||
Not using contraception | 11.5 | 12.0 |
Using contraception | 88.5 | 88.0 |
Among contraceptive users | ||
Any permanent method | 28.2 | 29.7 |
Female permanent contraception | 21.8 | 22.4 |
Vasectomy | 6.5 | 7.3 |
LARC method | 14.3 | 17.8∗ |
IUD | 11.8 | 13.5 |
Implant | 2.6 | 4.3∗ |
SARC method | 31.8 | 27.7∗ |
Pill | 25.3 | 21.9 |
Nonpill SARC methodb | 6.5 | 5.8 |
Any coitus-dependent method | 25.1 | 24.5 |
Condom | 14.5 | 15.2 |
Withdrawal | 8.1 | 6.9 |
Natural family planning | 2.2 | 2.4 |
Other coitus-dependent methodsc | 0.6 | 0.1∗ |
Note: Data presented as percentages. Survey years in column headings represent the midpoint of data collection years for each of the two National Survey of Family Growth (NSFG) surveys. Population includes all female respondents ages 15 to 44 years, weighted to reflect the U.S. female civilian population. LARC = long-acting reversible contraception; IUD = intrauterine device; SARC = short-acting reversible contraception.
Sexually active women not seeking pregnancy includes female respondents who had had sexual intercourse in the 3 months before interview, who were not pregnant or trying to conceive, and who were not sterile for noncontraceptive reasons.
Other nonpill SARC methods include the contraceptive patch, the vaginal ring, and the medroxyprogesterone injectable.
Other coitus-dependent methods include the diaphragm, foam, sponge, suppositories, jelly/cream, and “other methods” as indicated by the CONSTAT1 variable (contraceptive status recode prioritizing most effective method reported having been used during the month of the interview) in the NSFG documentation.
Indicates significant difference between the years at P < .05.